NCT07112274View on ClinicalTrials.gov

Empagliflozin on Patients With Preserved Heart Failure

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

July 30, 2025

Conditions
Heart Failure
Interventions
DRUG

Empagliflozin 10 MG

Treatment group will receive empagliflozin 10 mg tablet once daily

OTHER

Placebo Tablet

control group will receive placebo tablet.

Trial Locations (1)

31527

Rehab Hussein Werida, Damanhūr

All Listed Sponsors
lead

Damanhour University

OTHER